+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India Bioreactors Market to 2027 - Country Analysis and Forecasts by Product Class; Application; Process and Geography

  • ID: 4769895
  • Report
  • Region: India
  • 99 pages
  • The Insight Partners
1 of 4

FEATURED COMPANIES

  • Applikon Biotechnology BV
  • Biotree
  • DDE
  • General Electric
  • Praj Industries
  • Solaris Biotechnology Srl
  • MORE
The India bioreactors market is expected to reach US$ 164.8 Mn in 2027 from US$ 94.6 Mn in 2018. The market is estimated to grow with a CAGR of 6.6% from 2019-2027.

The growth of the bioreactors market is primarily attributed to the increasing number of bioreactors manufacturers, speedy evolution of pharmaceutical industry and aggressive pharmaceutical & biotechnological activities. However, concern of regulatory framework is likely to hinder the growth of the market during the forecast period. Additionally, the growth of the India bioreactors market is contributed by factors such as opportunities to develop personalized medicine. India is counted among the emerging nations where the biotechnology and pharmaceutical industry is growing rapidly. According to the Department for Promotion of Industry and Internal Trade Indian biotechnology industries is among the top 12 biotech destinations in the world and ranks third in the Asia Pacific. The country has the second highest number of the USFDA approved plants. In addition, approximately 104 new startups, 346 companies, 509 projects including 115 collaborative projects are being supported by the BIRAC, a Public Sector Unit of Government of India. Thus, the above mentioned factors are driving the growth of the India bioreactors market and is expected to continue in the future.

The advancement in the industry has made the Indian pharmaceutical industry to hold highest number (approximately 3,950) of Drug Master Files (DMFS) with USFDA by the end of 2016. In addition, it was expected that India's Abbreviated New Drug Applications (ANDAS) will have approximately 4,000 application by June 2017. According to the Department for Promotion of Industry and Internal Trade (Make in India) statistics the growth of the pharmaceuticals industry has earned approximately USD 16.8 billion from the exports of its API, generic and others medicinal products in between 2016-2017. Therefore, owing to these factors the pharmaceutical industry require higher number of the bioreactors for drug manufacturing. Thus, the increasing demand of the pharmaceutical products are leading to the growth of the bioreactors in India.

In 2017, the industrial scale (>1000L) bioreactors segment held a largest market share of 63.6% of the bioreactors market, by product. This segment is also expected to dominate the market in 2027 owing to increasing demand for industrial scale (>1000L) bioreactors in pharmaceutical companies. However, the pilot scale (15 - 1000L) bioreactors segment is anticipated to witness the fastest growth rate of 7.1% during the forecast period, 2019 to 2027 owing to the increased use of pilot scale bioreactors for research purposes.

Microbial application segment is anticipated to grow at a CAGR of 6.9% during the forecast period. The production of microbiologic and increasing government funding as well as promotional initiatives undertaken for usage of microbial products to treat medical conditions. Increasing R&D innovation in various other microbial applications has also been contributing significantly to the growth of the bioreactors market.

Some of the major primary and secondary sources for bioreactors included in the report are Abbreviated New Drug Applications (ANDAS), Department for Promotion of Industry and Internal Trade (Make in India), World Health Organization, Indian Drug and Pharmaceutical Limited, National Institutes of Pharmaceutical Education & Research (NIPERs) and others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Applikon Biotechnology BV
  • Biotree
  • DDE
  • General Electric
  • Praj Industries
  • Solaris Biotechnology Srl
  • MORE
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 REPORT GUIDANCE
1.3 MARKET SEGMENTATION

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research

4. BIOREACTORS MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 Bioreactors Market - India PEST Analysis
4.3 END USER (PHARMACEUTICAL INDUSTRY) MARKET ANALYSIS
4.3.1 End User (Pharmaceutical Industry) Market Analysis, By Product Class:
4.3.2 End User (Pharmaceutical Industry) Market Analysis, By Application
4.3.3 End User (Pharmaceutical Industry) Market Analysis, By Process

5. INDIA BIOREACTORS MARKET - KEY MARKET DYNAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Increasing Numbers of Bioreactors Manufacturers
5.1.2 Speedy Evolution of Pharmaceutical Industry
5.1.3 Aggressive Pharmaceutical and Biotechnological Activities
5.2 KEY MARKET RESTRAINTS
5.2.1 Concerns of Regulatory Framework
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Opportunities to Develop Personalized Medicine
5.4 FUTURE TRENDS
5.4.1 Use of Metagenomics in Pharmaceuticals
5.5 IMPACT ANALYSIS

6. BIOREACTORS MARKET - INDIA ANALYSIS
6.1 INDIA BIOREACTORS MARKET REVENUE FORECASTS AND ANALYSIS
6.2 PERFORMANCE OF KEY PLAYERS
6.2.1 Merck KGaA
6.2.2 Thermo Fisher Scientific Inc.

7. INDIA BIOREACTORS MARKET ANALYSIS-BY PRODUCT CLASS
7.1 OVERVIEW
7.1.1 India Bioreactors Market Revenue And Forecasts to 2027, By Product Class(US$ Mn)
7.2 BENCHTOP BIOREACTORS (UP TO 15 L) MARKET
7.2.1 Overview
7.2.2 India Benchtop Bioreactors (up to 15 L) Market Revenue and Forecasts to 2027 (US$ Mn)
7.3 PILOT SCALE BIOREACTORS (15-1000 L) MARKET
7.3.1 Overview
7.3.2 India Pilot Scale Reactors(15-1000 L) Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 INDUSTRIAL SCALE BIOREACTORS (>1000 L) MARKET
7.4.1 Overview
7.4.2 India Industrial Scale Bioreactors (>1000 L) Market Revenue and Forecasts to 2027 (US$ Mn)

8. INDIA BIOREACTORS MARKET ANALYSIS- BY APPLICATION
8.1 OVERVIEW
8.1.1 India Bioreactors Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.1.1.1 India Microbial Application Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.2 India Cell Culture Application Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2 MICROBIAL MARKET
8.2.1 Overview
8.2.2 India Microbial Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.3 Multi-Use Bioreactors Market
8.2.3.1 Overview
8.2.3.2 India Multi-Use Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.4 Single-Use Bioreactors Market
8.2.4.1 Overview
8.2.4.2 India Single-Use Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
8.3 CELL CULTURE MARKET
8.3.1 Overview
8.3.2 India Cell Culture Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.3 Multi-Use Bioreactors Market
8.3.3.1 Overview
8.3.3.2 India Multi-Use Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.4 Single-Use Bioreactors Market
8.3.4.1 Overview
8.3.4.2 India Single-Use Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)

9. INDIA BIOREACTORS MARKET ANALYSIS - PROCESS
9.1 OVERVIEW
9.1.1 India Bioreactors Market Revenue And Forecasts to 2027, By Process (US$ Mn)
9.2 RESEARCH & DEVELOPMENT MARKET
9.2.1 Overview
9.2.2 India Research & Development Market Revenue and Forecast to 2027 (US$ Mn)
9.3 PROCESS DEVELOPMENT MARKET
9.3.1 Overview
9.3.2 India Process Development Market Revenue and Forecast to 2027 (US$ Mn)
9.4 BIOPRODUCTION MARKET
9.4.1 Overview
9.4.2 India Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)

10. BIOREACTORS MARKET - INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 COMPARATIVE COMPANY ANALYSIS
10.3 GROWTH STRATEGIES IN THE BIOREACTORS MARKET, 2015-2018
10.4 ORGANIC GROWTH STRATEGIES
10.4.1 Overview
10.4.2 Expansions
10.4.3 Product Launches
10.4.4 Other Organic Growth Strategies
10.5 INORGANIC GROWTH STRATEGIES
10.5.1 Overview
10.5.2 Agreements
10.5.3 Acquisitions
10.5.4 Other Inorganic Growth Strategies

11. BIOREACTORS MARKET -KEY COMPANY PROFILES
11.1 MERCK KGAA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 APPLIKON BIOTECHNOLOGY BV
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 THERMO FISHER SCIENTIFIC INC.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 EPPENDORF
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BIOENGINEERING AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 SOLARIS BIOTECHNOLOGY SRL
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PRAJ INDUSTRIES
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SARTORIUS AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DANAHER (PALL CORPORATION)
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 GENERAL ELECTRIC
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 DDE
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 BIOZEEN
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 BIOTREE
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Financial Overview
11.13.4 Product Portfolio
11.13.5 SWOT Analysis
11.13.6 Key Developments
11.14 ZETA HOLDING GMBH
11.14.1 Key Facts
11.14.2 Business Description
11.14.3 Financial Overview
11.14.4 Product Portfolio
11.14.5 SWOT Analysis
11.14.6 Key Developments

12. APPENDIX
12.1 ABOUT THE PUBLISHER
12.2 GLOSSARY OF TERMS

LIST OF TABLES
TABLE 1. INDIA BIOREACTORS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT CLASS (US$ MN)
TABLE 2. INDIA BIOREACTORS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)
TABLE 3. INDIA MICROBIAL APPLICATION MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 4. INDIA CELL CULTURE APPLICATION MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. INDIA BIOREACTORS MARKET REVENUE AND FORECASTS TO 2027, BY PROCESS (US$ MN)
TABLE 6. RECENT EXPANSIONS IN THE BIOREACTORS MARKET
TABLE 7. RECENT PRODUCT LAUNCHES IN THE BIOREACTORS MARKET
TABLE 8. OTHER ORGANIC GROWTH STRATEGIES IN THE BIOREACTORS MARKET
TABLE 9. RECENT AGREEMENTS IN THE BIOREACTORS MARKET
TABLE 10. RECENT ACQUISITIONS IN THE BIOREACTORS MARKET
TABLE 11. RECENT OTHER INORGANIC GROWTH STRATEGIES IN THE BIOREACTORS MARKET
TABLE 12. GLOSSARY OF TERMS, INDIA BIOREACTORS MARKET

LIST OF FIGURES
FIGURE 1. BIOREACTORS MARKET SEGMENTATION
FIGURE 2. INDIA BIOREACTORS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
FIGURE 3. INDIA BIOREACTORS MARKET BY PRODUCT CLASS, MARKET SHARE (%), 2017
FIGURE 4. INDIA BIOREACTORS MARKET BY APPLICATION, MARKET SHARE (%), 2017
FIGURE 5. INDIA BIOREACTORS MARKET BY PROCESS, MARKET SHARE (%), 2017
FIGURE 6. BIOREACTORS MARKET - INDIA PEST ANALYSIS
FIGURE 7. END USER MARKET ANALYSIS, BY PRODUCT CLASS
FIGURE 8. END USER MARKET ANALYSIS, BY APPLICATION
FIGURE 9. END USER MARKET ANALYSIS, BY PROCESS
FIGURE 10. INDIA BIOREACTORS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS
FIGURE 11. INDIA BIOREACTORS MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2027
FIGURE 12. INDIA BIOREACTORS MARKET, BY PRODUCT CLASS 2017 & 2027 (%)
FIGURE 13. INDIA BENCHTOP BIOREACTORS (UP TO 15 L) MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 14. INDIA PILOT SCALE REACTORS (15-1000 L) MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 15. INDIA INDUSTRIAL SCALE BIOREACTORS (>1000 L) MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 16. INDIA BIOREACTORS MARKET, BY APPLICATION 2017 & 2027 (%)
FIGURE 17. INDIA MICROBIAL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. INDIA MULTI-USE BIOREACTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. INDIA SINGLE-USE BIOREACTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 20. INDIA CELL CULTURE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. INDIA MULTI-USE BIOREACTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. INDIA SINGLE-USE BIOREACTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. INDIA PROCESS MARKET ANALYSIS AND FORECASTS 2017 & 2027 (%)
FIGURE 24. INDIA RESEARCH & DEVELOPMENT MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. INDIA PROCESS DEVELOPMENT MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. INDIA BIOPRODUCTION MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 27. COMPARATIVE COMPANY ANALYSIS
FIGURE 28. GROWTH STRATEGIES IN THE BIOREACTORS MARKET, 2015-2018
FIGURE 29. ORGANIC GROWTH STRATEGIES IN THE BIOREACTORS MARKET, 2015-2018
FIGURE 30. INORGANIC GROWTH STRATEGIES IN THE BIOREACTOR MARKET, 2015-2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific Inc.
  • Applikon Biotechnology BV
  • Merck KGaA
  • Sartorius AG
  • Eppendorf
  • General Electric
  • Bioengineering AG
  • Solaris Biotechnology Srl
  • Danaher (Pall Corporation)
  • Praj Industries
  • DDE
  • BiOZEEN
  • Biotree
  • Zeta Holding GmbH
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769895
Adroll
adroll